Tirzepatide for Muscle Growth: What the Evidence Shows
What human and animal studies show about Tirzepatide for muscle growth, how strong that evidence is, and what is still unproven.
- Strongest evidence
- Human RCT
- Human studies
- 1
- with an outcome for muscle growth, in our evidence file (PubMed search, 2 Oct 2026)
- Animal studies
- None found
- with an outcome for muscle growth, in our evidence file (PubMed search, 2 Oct 2026)
- Studies we summarised
- 2
- with an outcome for muscle growth
Evidence for muscle growth
Each row is an outcome related to muscle growth from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Fat mass and lean mass | At week 72, body weight, fat mass and lean mass changed by -21.3%, -33.9% and -10.9% with tirzepatide vs -5.3%, -8.2% and -2.6% with placebo. | Human RCTn = 160 | Diabetes, obesity & metabolism 2025, PMID 39996356 |
| Share of weight lost as fat | About 75% of weight lost was fat mass and 25% lean mass, for both tirzepatide and placebo. | Human RCTn = 160 | Diabetes, obesity & metabolism 2025, PMID 39996356 |
| Lean mass loss with GLP-1 agonists | Lean mass loss made up approximately 25% of total weight loss across the drug class. | Meta-analysisn = 2258 | Metabolism: clinical and experimental 2025, PMID 39719170 |
| Tirzepatide and lean mass | Tirzepatide 15 mg weekly and semaglutide 2.4 mg weekly were most effective for weight and fat mass loss but among the least effective at preserving lean mass. | Meta-analysisn = 2258 | Metabolism: clinical and experimental 2025, PMID 39719170 |
Tirzepatide and muscle growth are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Tirzepatide and muscle: what DXA scans show
MedlinePlus describes strength training as exercise using weights, resistance bands or your own body weight to build stronger muscles.[3]
In a SURMOUNT-1 DXA substudy, weight, fat mass and lean mass all fell: 21.3%, 33.9% and 10.9% with tirzepatide, against 5.3%, 8.2% and 2.6% with placebo.[1]
Of the weight lost, roughly 75% was fat and 25% lean mass for both tirzepatide and placebo, so the proportion was consistent even though the amounts differed.[1]
Pooled evidence
A meta-analysis of body-composition trials found tirzepatide at 15 mg and semaglutide at 2.4 mg were the most effective for weight and fat loss but among the least effective at preserving lean mass.[2]
A network meta-analysis reported that tirzepatide reduced fat mass the most, by 25.7%, and lean mass the most too, by 8.3%.[4]
That meta-analysis focused on total weight, fat mass and lean mass in adults with diabetes and/or overweight or obesity, not on strength or muscle-building outcomes.[2]
Other peptides people research for muscle growth
All peptides for muscle growth, comparedCommon questions
Does Tirzepatide help with muscle growth?
The strongest study we summarise for muscle growth is human rct evidence, across 2 studies with an outcome for muscle growth. A trial result is not an approval; see the legal status.
Is Tirzepatide approved for muscle growth?
Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for muscle growth?
There is no single answer. Our muscle growth overview compares each candidate by evidence grade and legal status rather than by popularity.
Does tirzepatide build muscle?
In the SURMOUNT-1 DXA substudy, lean mass fell 10.9% with tirzepatide against 2.6% with placebo.[1]
How much muscle do you lose on tirzepatide?
About 25% of the weight lost was lean mass in SURMOUNT-1, the same share as on placebo.[1]
Is tirzepatide used for bodybuilding or cutting?
The evidence cited here comes from weight-loss studies. A review says potent GLP-1 drugs such as tirzepatide give greater overall weight loss but are associated with a significant reduction in lean mass.[2]
More on Tirzepatide
Sources
- 1Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight.Diabetes, obesity & metabolism · 2025PMID 39996356Accessed 2 Oct 2026
- 2Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.Metabolism: clinical and experimental · 2025PMID 39719170Accessed 2 Oct 2026
- 3Official web pageOfficial web page · web page
- 4Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis.BMJ (Clinical research ed.) · 2026PMID 42419792Accessed 2 Oct 2026
Found an error? Report a correction.